Skip to main content

Advertisement

SpringerLink
Log in

NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

The risk of chronic liver disease and liver-related mortality is increased in patients with type 2 diabetes mellitus. Several cohort studies have suggested a metabolic pathway from nonalcoholic fatty liver, nonalcoholic steatohepatitis, cryptogenic cirrhosis, and eventually hepatocellular carcinoma. Although cardiovascular risk remains the major cause for excess mortality in type 2 diabetes mellitus, the risk of progressive liver disease should no longer be underscored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Falck-Ytter Y, Younossi ZM, Marchesini G, et al.: Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001, 21:17–26.

    Article  PubMed  CAS  Google Scholar 

  2. Bellentani S, Saccoccio G, Masutti F, et al.: Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000, 132:112–117.

    PubMed  CAS  Google Scholar 

  3. Clark JM, Brancati FL, Diehl AM: Nonalcoholic fatty liver disease. Gastroenterology 2002, 122:1649–1657.

    Article  PubMed  Google Scholar 

  4. Marchesini G, Bugianesi E, Forlani G, et al.: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37:917–923.

    Article  PubMed  Google Scholar 

  5. Bugianesi E, McCullough AJ, Marchesini G: Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005, 42:987–1000.

    Article  PubMed  CAS  Google Scholar 

  6. Browning JD, Szczepaniak LS, Dobbins R, et al.: Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387–1395.

    Article  PubMed  Google Scholar 

  7. Ricci C, Longo R, Gioulis E, et al.: Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997, 27:108–113.

    Article  PubMed  CAS  Google Scholar 

  8. Mofrad P, Contos MJ, Haque M, et al.: Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003, 37:1286–1292.

    Article  PubMed  Google Scholar 

  9. Simo R, Hernandez C, Genesca J, et al.: High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996, 19:998–1000.

    Article  PubMed  CAS  Google Scholar 

  10. Gu K, Cowie CC, Harris MI: Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993. Diabetes Care 1998, 21:1138–1145.

    Article  PubMed  CAS  Google Scholar 

  11. Roper NA, Bilous RW, Kelly WF, et al.: Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. Diabetes Care 2002, 25:43–48.

    Article  PubMed  Google Scholar 

  12. Bianchi G, Marchesini G, Zoli M, et al.: Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994, 20:119–125.

    PubMed  CAS  Google Scholar 

  13. de Marco R, Locatelli F, Zoppini G, et al.: Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care 1999, 22:756–761.

    Article  PubMed  Google Scholar 

  14. Mason AL, Lau JY, Hoang N, et al.: Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 29:328–333.

    Article  PubMed  CAS  Google Scholar 

  15. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221–1231.

    Article  PubMed  CAS  Google Scholar 

  16. El-Serag HB, Tran T, Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004, 126:460–468.

    Article  PubMed  Google Scholar 

  17. Jimba S, Nakagami T, Takahashi M, et al.: Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005, 22:1141–1145.

    Article  PubMed  CAS  Google Scholar 

  18. Chitturi S, Abeygunasekera S, Farrell GC, et al.: NASH and insulin resistance: insulin secretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35:373–379.

    Article  PubMed  CAS  Google Scholar 

  19. Marchesini G, Avagnina S, Barantani EG, et al.: Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest 2005, 28:333–339.

    PubMed  CAS  Google Scholar 

  20. Targher G, Bertolini L, Poli F, et al.: Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005, 54:3541–3546.

    Article  PubMed  CAS  Google Scholar 

  21. Ratziu V, Giral P, Charlotte F, et al.: Liver fibrosis in overweight patients. Gastroenterology 2000, 118:1117–1123.

    Article  PubMed  CAS  Google Scholar 

  22. Silverman JF, Pories WJ, Caro JF: Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations. Pathol Annu 1989, 24:275–302.

    PubMed  Google Scholar 

  23. Dixon JB, Bhathal PS, O’Brien PE: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121:91–100.

    Article  PubMed  CAS  Google Scholar 

  24. Gupte P, Amarapurkar D, Agal S, et al.: Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004, 19:854–858.

    Article  PubMed  Google Scholar 

  25. Villanova N, Moscatiello S, Ramilli S, et al.: Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005, 42:473–480.

    Article  PubMed  Google Scholar 

  26. Alexandraki K, Piperi C, Kalofoutis C, et al.: Inflammatory process in type 2 diabetes: the role of cytokines. Ann N Y Acad Sci 2006, 1084:89–117.

    Article  PubMed  CAS  Google Scholar 

  27. Targher G, Bertolini L, Padovani R, et al.: Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006, 29:1325–1330.

    Article  PubMed  Google Scholar 

  28. Yki-Jarvinen H, Westerbacka J: The fatty liver and insulin resistance. Curr Mol Med 2005, 5:287–295.

    Article  PubMed  CAS  Google Scholar 

  29. El-Serag HB, Everhart JE: Diabetes increases the risk of acute hepatic failure. Gastroenterology 2002, 122:1822–1828.

    Article  PubMed  Google Scholar 

  30. Caldwell SH, Hespenheide EE: Subacute liver failure in obese women. Am J Gastroenterol 2002, 97:2058–2062.

    Article  PubMed  Google Scholar 

  31. Caldwell SH, Crespo DM: The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 2004, 40:578–584.

    Article  PubMed  Google Scholar 

  32. Poonawala A, Nair SP, Thuluvath PJ: Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000, 32:689–692.

    Article  PubMed  CAS  Google Scholar 

  33. Ratziu V, Bonyhay L, Di Martino V, et al.: Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002, 35:1485–1493.

    Article  PubMed  Google Scholar 

  34. Hui JM, Kench JG, Chitturi S, et al.: Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003, 38:420–427.

    Article  PubMed  Google Scholar 

  35. Younossi ZM, Gramlich T, Matteoni CA, et al.: Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004, 2:262–265.

    Article  PubMed  Google Scholar 

  36. Lawson DH, Gray JM, McKillop C, et al.: Diabetes mellitus and primary hepatocellular carcinoma. Q J Med 1986, 61:945–955.

    PubMed  CAS  Google Scholar 

  37. Adami HO, McLaughlin J, Ekbom A, et al.: Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991, 2:307–314.

    Article  PubMed  CAS  Google Scholar 

  38. Yu MC, Tong MJ, Govindarajan S, et al.: Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991, 83:1820–1826.

    Article  PubMed  CAS  Google Scholar 

  39. Wideroff L, Gridley G, Mellemkjaer L, et al.: Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997, 89:1360–1365.

    Article  PubMed  CAS  Google Scholar 

  40. Lagiou P, Kuper H, Stuver SO, et al.: Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000, 92:1096–1099.

    Article  PubMed  CAS  Google Scholar 

  41. Trombetta M, Spiazzi G, Zoppini G, et al.: Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. Aliment Pharmacol Ther 2005, 22(suppl 2):24–27.

    Article  PubMed  Google Scholar 

  42. Calle EE, Rodriguez C, Walker-Thurmond K, et al.: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625–1638.

    Article  PubMed  Google Scholar 

  43. Davila JA, Morgan RO, Shaib Y, et al.: Diabetes increases the risk of hepatocellular carcinoma in the United States: a population-based case control study. Gut 2005, 54:533–539.

    Article  PubMed  CAS  Google Scholar 

  44. El-Serag HB: Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004, 127:S27–S34.

    Article  PubMed  Google Scholar 

  45. Jee SH, Ohrr H, Sull JW, et al.: Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005, 293:194–202.

    Article  PubMed  CAS  Google Scholar 

  46. Marrero JA, Fontana RJ, Su GL, et al.: NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002, 36:1349–1354.

    PubMed  Google Scholar 

  47. Adams LA, Lymp JF, St Sauver J, et al.: The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113–121.

    Article  PubMed  Google Scholar 

  48. Ganne-Carrie N, Ziol M, de Ledinghen V, et al.: Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006, 44:1511–1517.

    Article  PubMed  Google Scholar 

  49. Angulo P, Keach JC, Batts KP, et al.: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999, 30:1356–1362.

    Article  PubMed  CAS  Google Scholar 

  50. Harrison SA, Torgerson S, Hayashi PH: The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003, 98:2042–2047.

    Article  PubMed  Google Scholar 

  51. Angulo P, George J, Marchesini G, et al.: The NAFLD fibrosis score: a simple noninvasive system that accurately identifies liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2007, in press.

Download references

Author information

Authors and Affiliations

  1. Division of Gastro-Hepatology, University of Turin, S. Giovanni Battista Hospital, Corso Bramante 88, Turin, 10126, Italy

    Elisabetta Bugianesi MD

Authors
  1. Elisabetta Bugianesi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ester Vanni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giulio Marchesini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elisabetta Bugianesi MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bugianesi, E., Vanni, E. & Marchesini, G. NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. Curr Diab Rep 7, 175–180 (2007). https://doi.org/10.1007/s11892-007-0029-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-007-0029-z

Keywords

Search

Navigation